131 lines
4.9 KiB
Markdown
131 lines
4.9 KiB
Markdown
# Signal — Asset Sale Overview
|
||
## Plain Language Edition
|
||
### For Social Sharing and Non-Technical Decision Makers
|
||
|
||
---
|
||
|
||
> SIGNAL
|
||
> Stop Losing 20% of Your Clients' CGM Revenue.
|
||
> A ready-to-deploy tool for DME billing companies.
|
||
> STTIL Solutions LLC | kisasttil@gmail.com
|
||
|
||
---
|
||
|
||
### The Problem. In Plain English.
|
||
|
||
Right now, your clients are losing money they don't have to lose.
|
||
|
||
For every $100 they bill on CGM (continuous glucose monitors), about **$20
|
||
disappears.** It doesn't go to fraud. It doesn't go to bad patients. It goes
|
||
to paperwork that wasn't ready on time.
|
||
|
||
A claim gets denied. The product was already shipped. The patient has it. Your
|
||
client can't get it back. They try to appeal. Most of the time, they lose more
|
||
money fighting it than they get back.
|
||
|
||
Here's the part that stings: CMS data shows **nearly 1 in 3 CGM claims
|
||
has an error — and documentation problems cause more than two-thirds of
|
||
those failures.** The information existed. Someone just didn't have it
|
||
in hand before the order shipped.
|
||
|
||
That's what Signal fixes.
|
||
|
||
---
|
||
|
||
### What Goes Wrong — and When We Catch It
|
||
|
||
There are six places in the workflow where a claim goes from "fine" to "denied."
|
||
We catch all six **before the product ships**, not after.
|
||
|
||
**1. Prior Authorization — the biggest one.**
|
||
No PA before shipment = no money, period. No appeals, no second chances. We
|
||
make sure PA is confirmed 45 days before the order goes out the door.
|
||
|
||
**2. The Coverage Clock.**
|
||
Every CGM patient has a refill schedule. We track it for every patient, every
|
||
month. This is the engine everything else runs on.
|
||
|
||
**3. The 6-Month Doctor Visit.**
|
||
Medicare requires a check-in with the prescribing doctor every 6 months for
|
||
CGM patients to keep getting supplies. When that visit doesn't happen, the
|
||
claim gets denied. We flag it a month before it becomes a problem.
|
||
|
||
**4. Prescriber Enrollment Check.**
|
||
If the doctor who ordered the CGM isn't currently enrolled in Medicare, the
|
||
claim gets denied — even if everything else is perfect. We re-check this every
|
||
time an order is about to ship, not just when the patient first signs up.
|
||
|
||
**5. New Patient Setup.**
|
||
Before anyone's first order ships, we check eligibility, duplicate claims, and
|
||
whether the right supplier is on file with CMS. Bad setups become expensive
|
||
surprises later.
|
||
|
||
**6. Audit Defense — the safety net.**
|
||
Every check we run gets logged with a time stamp. If CMS ever audits one of
|
||
your clients, that log shows exactly what was verified and when. It's proof
|
||
they were doing things right.
|
||
|
||
---
|
||
|
||
### Try It First. On Your Own Client Data.
|
||
|
||
We're offering a **60-day pilot** at no cost.
|
||
|
||
Pick two to three of your suppliers. We run Signal on their live CGM
|
||
patient data. We track what would have been denied. We show you what changed.
|
||
|
||
At the end of 60 days, you'll see the before-and-after in your clients' actual
|
||
numbers — not in a demo, not in a made-up scenario.
|
||
|
||
If it doesn't show a clear improvement in first-pass CGM claims, there's no deal.
|
||
|
||
---
|
||
|
||
### What We're Asking
|
||
|
||
Signal is available two ways:
|
||
|
||
**Option 1 — You own it.**
|
||
One-time purchase: **$45,000–$65,000.**
|
||
You get the full code, all the research, 30 days of live handoff sessions, and
|
||
the AI development context so your team can keep building. You white-label it.
|
||
You charge your clients. The revenue is yours.
|
||
|
||
**Option 2 — Per-client licensing.**
|
||
**$75 per supplier client per month.**
|
||
If you have 20 CGM-active clients, that's $1,500/month. You pass the cost
|
||
through at whatever margin makes sense for your business.
|
||
|
||
---
|
||
|
||
### Three Questions You're Probably Already Thinking
|
||
|
||
**"Is this worth the cost?"**
|
||
Your clients are losing $20 of every $100 they bill on CGM. If Signal
|
||
moves that to $14 lost instead of $20 — a modest improvement — a single
|
||
500-patient supplier recovers $9,000+ per month. At $75/month, that's a
|
||
120-to-1 return. The cost question answers itself.
|
||
|
||
**"Doesn't this make my billing services less necessary?"**
|
||
No. Your clients still need you to run their billing, handle denials, and
|
||
manage payer relationships. Signal handles the pre-shipment window — the
|
||
45 days before a claim exists. That's not your current job. It becomes a new
|
||
service you offer, not a replacement for what you already do.
|
||
|
||
**"What happens to patient data?"**
|
||
Signal never stores patient names, Social Security numbers, dates of birth,
|
||
or contact information. The only identifier the system uses is the supplier's
|
||
internal patient ID number. All audit logs hash even that. Data stays on your
|
||
infrastructure, not ours. A Business Associate Agreement is part of every
|
||
deployment.
|
||
|
||
---
|
||
|
||
**Ready to run the pilot?**
|
||
Contact: kisasttil@gmail.com
|
||
STTIL Solutions LLC | Signal
|
||
|
||
---
|
||
|
||
*Key data: CMS 2024 CGM improper payment rate 25.2% / $278.5M projected annual.*
|
||
*Source: [CMS Glucose Monitoring Compliance](https://www.cms.gov/training-education/medicare-learning-networkr-mln/compliance/medicare-provider-compliance-tips/glucose-monitoring-supplies)*
|